Search Results 401-410 of 19486 for alzheimers
Genome-wide association studies of late-onset Alzheimer's disease (LOAD) have identified many risk variants. The lab has assessed the association of the top ...
"Screening for the sleep disorder in a patient with dementia could help clinicians diagnose either dementia with Lewy bodies or Alzheimer's disease," she says.
The Food and Drug Administration (FDA) granted traditional approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's ...
View faculty and staff of Mayo Clinic's Neurobiology of Alzheimer's Disease and Related Dementias Lab in Florida led by Na Zhao, M.D., Ph.D.
The study builds on previous research that identified genetic risk factors for Alzheimer's disease and established that RNA molecules in blood plasma could ...
“This study showed, for the first time, that the brain amyloid deposition ─ a hallmark of Alzheimer's disease ─ is reduced in newly postmenopausal women who ...
Dr. Ertekin-Taner's laboratory aims to discover and characterize genetic factors underlying the complex genetics of Alzheimer's disease (AD) and related ...
Learn how Mayo Clinic's Dr. Floyd Willis is connecting minority patients to Alzheimer's Disease research, clinical trials and care.
A multidisciplinary faculty guides research in the Mayo Clinic Alzheimer's Disease Research Center.
The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in subjects with early Alzheimer's disease (AD). Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.